Andrew S Tubbs1, Sadia B Ghani1, Michelle Naps2, Michael A Grandner1, Michael D Stein3,4, Subhajit Chakravorty5,6. 1. Sleep and Health Research Program, Department of Psychiatry, University of Arizona College of Medicine-Tucson, Tucson, Arizona. 2. School of Engineering and Applied Science, University of Pennsylvania, Philadelphia, Pennsylvania. 3. Department of Health Law, Policy, and Management, Boston University School of Public Health, Boston, Massachusetts. 4. Behavioral Medicine and Addictions Research Unit, Butler Hospital, Providence, Rhode Island. 5. Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. 6. Departments of Psychiatry and Research and Development, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania.
Abstract
STUDY OBJECTIVES: Prescription use and misuse of opioids are linked to greater sleep disturbance. However, there are limited data on the prevalence of sedative-hypnotic medication use among persons who use opioids. Therefore, this study examined whether past-year sedative-hypnotic use among persons who used/misused opioids was higher than among individuals who did not use opioids. METHODS: Data were acquired from the US National Survey on Drug Use and Health for 2015-2018. Use of a sedative benzodiazepine (temazepam, flurazepam, triazolam) or a Z-drug (eszopiclone, zaleplon, zolpidem) was examined in relation to use/misuse of an opioid within the past year. Logistic regression models estimated the associations between opioids and sedative-hypnotics using inverse probability of treatment weighting. A secondary machine learning analysis tested 6 binary classifiers to predict sedative-hypnotic use based on opioid use/misuse and other covariates. RESULTS: Of 171,766 respondents, 24% used a prescription opioid whereas 3.6% misused an opioid in the past year. Among those who used a prescription opioid, 1.9% received a sedative benzodiazepine and 9% received a Z-drug during the same time frame. Use of an opioid was associated with greater odds of sedative benzodiazepine use (odds ratio, 4.4; 95% confidence interval, 3.61-5.4) and Z-drug use (odds ratio, 3.8; 95% confidence interval, 3.51-4.09), and stronger associations were noted for misuse of an opioid. Machine learning models accurately classified sedative-hypnotic medication use for > 70% of respondents based on opioid use/misuse. CONCLUSIONS: Sedative-hypnotic use is common among persons who use opioids, which is of concern given the elevated mortality risk with concurrent use of these substances. CITATION: Tubbs AS, Ghani SB, Naps M, Grandner MA, Stein MD, Chakravorty S. Past-year use or misuse of an opiod is associated with use of a sedative-hypnotic medication: a US National Survey on Drug Use and Health (NSDUH) study. J Clin Sleep Med. 2022;18(3):809-816.
STUDY OBJECTIVES: Prescription use and misuse of opioids are linked to greater sleep disturbance. However, there are limited data on the prevalence of sedative-hypnotic medication use among persons who use opioids. Therefore, this study examined whether past-year sedative-hypnotic use among persons who used/misused opioids was higher than among individuals who did not use opioids. METHODS: Data were acquired from the US National Survey on Drug Use and Health for 2015-2018. Use of a sedative benzodiazepine (temazepam, flurazepam, triazolam) or a Z-drug (eszopiclone, zaleplon, zolpidem) was examined in relation to use/misuse of an opioid within the past year. Logistic regression models estimated the associations between opioids and sedative-hypnotics using inverse probability of treatment weighting. A secondary machine learning analysis tested 6 binary classifiers to predict sedative-hypnotic use based on opioid use/misuse and other covariates. RESULTS: Of 171,766 respondents, 24% used a prescription opioid whereas 3.6% misused an opioid in the past year. Among those who used a prescription opioid, 1.9% received a sedative benzodiazepine and 9% received a Z-drug during the same time frame. Use of an opioid was associated with greater odds of sedative benzodiazepine use (odds ratio, 4.4; 95% confidence interval, 3.61-5.4) and Z-drug use (odds ratio, 3.8; 95% confidence interval, 3.51-4.09), and stronger associations were noted for misuse of an opioid. Machine learning models accurately classified sedative-hypnotic medication use for > 70% of respondents based on opioid use/misuse. CONCLUSIONS: Sedative-hypnotic use is common among persons who use opioids, which is of concern given the elevated mortality risk with concurrent use of these substances. CITATION: Tubbs AS, Ghani SB, Naps M, Grandner MA, Stein MD, Chakravorty S. Past-year use or misuse of an opiod is associated with use of a sedative-hypnotic medication: a US National Survey on Drug Use and Health (NSDUH) study. J Clin Sleep Med. 2022;18(3):809-816.
Authors: Richard Hallinan; Mahmoud Elsayed; David Espinoza; Anna-Sophie Veillard; Kirsten C Morley; Nick Lintzeris; Paul Haber Journal: Subst Use Misuse Date: 2019-05-26 Impact factor: 2.164
Authors: Emily E Hartwell; James G Pfeifer; Jenna L McCauley; Megan Moran-Santa Maria; Sudie E Back Journal: Addict Behav Date: 2014-06-02 Impact factor: 3.913
Authors: Christopher N Kaufmann; Adam P Spira; G Caleb Alexander; Lainie Rutkow; Ramin Mojtabai Journal: Pharmacoepidemiol Drug Saf Date: 2015-12-29 Impact factor: 2.890
Authors: Michael A Grandner; Nicholas J Jackson; Bilgay Izci-Balserak; Rebecca A Gallagher; Renee Murray-Bachmann; Natasha J Williams; Nirav P Patel; Girardin Jean-Louis Journal: Front Neurol Date: 2015-06-05 Impact factor: 4.003
Authors: Sarah L Garnaat; Risa B Weisberg; Lisa A Uebelacker; Debra S Herman; Genie L Bailey; Bradley J Anderson; Katherine M Sharkey; Michael D Stein Journal: Subst Abus Date: 2017-09-13 Impact factor: 3.716